• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec5
Alibaba Health Reports Strong First Half of Fiscal 2026, Revenue Reaches RMB 166.97 Billion
02:08
Dec4
Guotai Junan Maintains Buy Rating on Ali Health Information Technology with Target Price of HKD 5.69
05:36
Dec2
JPMorgan 增持阿里健康
10:59
Goldman Sachs Maintains Neutral Rating on Alibaba Health and Raises Target Price
09:14
Daiwa Capital Predicts Continued Growth for Alibaba Health, Maintains Buy Rating
03:59
UBS Raises Target Price for Alibaba Health but Maintains 'Sell' Rating
03:01

Schedules & Filings

Schedules
Filings
Nov26
Earning Release(CST)

FY2026 Q2 Earning Release (HKD) Revenue 9.126 B, Net Income 692.32 M, EPS 0.0427

May19
Earning Release(CST)

FY2025 Q4 Earning Release (HKD) Revenue 8.742 B, Net Income 355.28 M, EPS 0.0219

Nov13
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 7.911 B, Net Income 426.17 M, EPS 0.0264

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
08413
0.211
+83.48%
+0.096
08186
0.740
+55.79%
+0.265
02135
0.188
+37.23%
+0.051
01239
0.390
+23.81%
+0.075
00209
0.179
+20.95%
+0.031
01371
0.290
+20.83%
+0.050
02971
0.012
+20.00%
+0.002
02227
0.189
+19.62%
+0.031
06958
0.135
+17.39%
+0.020
02521
0.560
+16.67%
+0.080
View More